Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNCL002688

Drug Information
Trade NameZybrestat
CompanyOXiGENE South San Francisco, CA
IndicationFirst-line NSCLC (see also ovarian)
[ICD9: 162, 183   ICD10: C33, C34, C56]
Phase II    
Ovarian CancerPhase II    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCOC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)(O)O    
Isomeric SMILESCOC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)OP(=O)(O)O
PubChem Compound IDCID 5351387.


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543